Wednesday December 30, 2015 0 comments
CENTENNIAL -- AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft tissue allografts of use in surgical procedures and wound care to advance patient healing, announced it received two new patents from the U.S. Patent Office for cartilage repair allografts.
Patent No. 9,168,140 covers donated osteochondral tissue with a bone-and-cartilage layer perforated with small holes to allow for cellular migration and osteochondral repair, the company said.
Patent No. 9,186,380 covers donated cartilage tissue processed to include small particles of cartilage containing living chondrocytes.
“The continued expansion of our intellectual property portfolio illustrates our dedication to growth and innovation,” said Thomas Cycyota, AlloSource president and CEO.
“AlloSource is passionate about developing new solutions for the medical community and will continue to be motivated by finding ways to honor the gift of human tissue donation by helping patients heal.”
The company said its safety and tissue processing standards meet and exceed guidelines of the U.S. FDA and the American Association of Tissue Banks.